United Kingdom Medical QMS Software Market Size & Outlook, 2026-2034
United Kingdom Medical QMS Software Market Insights
- As highlighted in Reed Intelligence analysis, the United Kingdom Medical QMS Software Market, worth USD 42.15 Million in 2025, is forecasted to achieve USD 163.91 Million by 2034.
- The United Kingdom market is anticipated to grow at a CAGR of 16.14% during the period 2026–2034.
- By 2025, Complaint Handling represented the largest share of the By Solution Type market size.
- Complaint Handling is expected to remain the key growth driver within By Solution Type, registering the fastest CAGR during the forecast period.
![United Kingdom Medical QMS Software Market Size, Share & Growth Report By [2034]](https://reedintelligence.com/uploads/charts/united-kingdom-medical-qms-software-market-united-kingdom-by-solution-type-244162.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United Kingdom accounted for 6.23% of the global Medical QMS Software Market size in 2025.
- By 2034, United States is expected to remain the top global market in terms of size.
- Within Europe, Germany is forecasted to dominate the regional Medical QMS Software Market size by 2034.
- Germany will be the fastest-growing market in Europe, projected to achieve USD 198.77 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 42.15 Million |
| Market Size In 2034 | USD 163.91 Million |
| Largest segment | Complaint Handling |
| Units | Revenue in USD Million |
| CAGR | 16.14% (2026-2034) |
| Segmnetation Covered | |
| By Solution Type |
|
| By Deployment Type |
|
| By End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Medical QMS Software Market By Solution Type 2026-2034 (USD Million)
| By Solution Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Complaint Handling | XX.x | XX.x | XX.x | 12.9 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Document Control | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Audit Management | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-conformances/ Corrective & Preventive | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Supplier Quality Management | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Kingdom Medical QMS Software Market By Deployment Type 2026-2034 (USD Million)
| By Deployment Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| On-premises | XX.x | XX.x | XX.x | 27.17 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cloud-based | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Kingdom Medical QMS Software Market By End User 2026-2034 (USD Million)
| By End User | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMEs | XX.x | XX.x | XX.x | 26.65 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Large Enterprises | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.